Valley National Advisers’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Valley National Advisers’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,000	Closed	-$371K	–	1004
2023 Q1	$371K	Hold	3,000	–	–	0.07%	196
2022 Q4	$341K	Hold	3,000	–	–	0.06%	203
2022 Q3	$322K	Hold	3,000	–	–	0.07%	200
2022 Q2	$307K	Buy	+3,000	New	+$327K	0.06%	190

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Valley National Advisers's BSX.PRA Position: Q2 2023 in Review

Valley National Advisers sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 3,000 shares — an estimated $371K sold.

Valley National Advisers first reported a position in BSX.PRA in Q2 2022 and held it in 4 quarters. The position peaked at $371K in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Valley National Advisers reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Valley National Advisers sold 3,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $371K.
Valley National Advisers first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2022 and held it in 4 quarters.
Valley National Advisers's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $371K in Q1 2023.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Valley National Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.